Sialyllactose Preserves Residual Hearing After Cochlear Implantation

Overview

Journal Sci Rep

Specialty Science

Date 2024 Jun 11

PMID 38862572

Authors

Min Young Lee

Seo-Kyung Jung

Jongmoon Jang

Hongsoo Choi

Yun-Hoon Choung

Jeong Hun Jang

Affiliations

Soon will be listed here.

Abstract

In individuals with hearing loss, protection of residual hearing is essential following cochlear implantation to facilitate acoustic and electric hearing. Hearing preservation requires slow insertion, atraumatic electrode and delivery of the optimal quantity of a pharmacological agent. Several studies have reported variable hearing outcomes with osmotic pump-mediated steroid delivery. New drugs, such as sialyllactose (SL) which have anti-inflammatory effect in many body parts, can prevent tissue overgrowth. In the present study, the positive effects of the pharmacological agent SL against insults were evaluated in vitro using HEI-OC1 cells. An animal model to simulate the damage due to electrode insertion during cochlear implantation was used. SL was delivered using osmotic pumps to prevent loss of the residual hearing in this animal model. Hearing deterioration, tissue fibrosis and ossification were confirmed in this animal model. Increased gene expressions of inflammatory cytokines were identified in the cochleae following dummy electrode insertion. Following the administration of SL, insertion led to a decrease in hearing threshold shifts, tissue reactions, and inflammatory markers. These results emphasize the possible role of SL in hearing preservation and improve our understanding of the mechanism underlying hearing loss after cochlear implantation.

References

Jang J, Kim J, Cheol Kim Y, Kim S, Chou N, Lee S . A 3D Microscaffold Cochlear Electrode Array for Steroid Elution. Adv Healthc Mater. 2019; 8(20):e1900379. DOI: 10.1002/adhm.201900379. View

Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M . The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55(4):611-22. DOI: 10.1373/clinchem.2008.112797. View

Holt J, Raphael Y . Introduction to the Hearing Research special issue on inner ear gene therapy. Hear Res. 2020; 394:108010. DOI: 10.1016/j.heares.2020.108010. View

Gotamco G, Chou Y, Sun C, Hsu C, Chen P, Wu H . Comparison of Hearing Preservation Outcomes Using Extended Versus Single-Dose Steroid Therapy in Cochlear Implantation. Otol Neurotol. 2020; 41(4):e449-e457. DOI: 10.1097/MAO.0000000000002570. View

Honda Y, Tanaka N, Kajiwara Y, Kondo Y, Kataoka H, Sakamoto J . Effect of belt electrode-skeletal muscle electrical stimulation on immobilization-induced muscle fibrosis. PLoS One. 2021; 16(5):e0244120. PMC: 8118259. DOI: 10.1371/journal.pone.0244120. View

Eshraghi A, Adil E, He J, Graves R, Balkany T, van de Water T . Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol. 2007; 28(6):842-9. DOI: 10.1097/mao.0b013e31805778fc. View

Maeda K, Yoshida K, Ichimiya I, Suzuki M . Dexamethasone inhibits tumor necrosis factor-alpha-induced cytokine secretion from spiral ligament fibrocytes. Hear Res. 2005; 202(1-2):154-60. DOI: 10.1016/j.heares.2004.08.022. View

deTorres A, Olszewski R, Lopez I, Ishiyama A, Linthicum Jr F, Hoa M . Supporting cell survival after cochlear implant surgery. Laryngoscope. 2018; 129(1):E36-E40. PMC: 6320269. DOI: 10.1002/lary.27539. View

Astolfi L, Simoni E, Giarbini N, Giordano P, Pannella M, Hatzopoulos S . Cochlear implant and inflammation reaction: Safety study of a new steroid-eluting electrode. Hear Res. 2016; 336:44-52. DOI: 10.1016/j.heares.2016.04.005. View

10.

Chadha S, Kamenov K, Cieza A . The world report on hearing, 2021. Bull World Health Organ. 2021; 99(4):242-242A. PMC: 8085630. DOI: 10.2471/BLT.21.285643. View

11.

Lenarz T . Electro-acoustic stimulation of the cochlea. Editorial. Audiol Neurootol. 2009; 14 Suppl 1:1. DOI: 10.1159/000206488. View

12.

Smouha E . Surgery of the inner ear with hearing preservation: serial histological changes. Laryngoscope. 2003; 113(9):1439-49. DOI: 10.1097/00005537-200309000-00003. View

13.

Rutherford B, Brewster K, Golub J, Kim A, Roose S . Sensation and Psychiatry: Linking Age-Related Hearing Loss to Late-Life Depression and Cognitive Decline. Am J Psychiatry. 2017; 175(3):215-224. PMC: 5849471. DOI: 10.1176/appi.ajp.2017.17040423. View

14.

Shaul C, Venkatagiri P, Lo J, Eastwood H, Bester C, Briggs R . Glucocorticoid for Hearing Preservation After Cochlear Implantation: A Systemic Review and Meta-analysis of Animal Studies. Otol Neurotol. 2019; 40(9):1178-1185. DOI: 10.1097/MAO.0000000000002383. View

15.

Takemura K, Komeda M, Yagi M, Himeno C, Izumikawa M, Doi T . Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in guinea pig. Hear Res. 2004; 196(1-2):58-68. DOI: 10.1016/j.heares.2004.06.003. View

16.

Chou C, Hsieh T, Chen J, Fang T . Sudden Sensorineural Hearing Loss in Hemodialysis Patients Could be a Marker of Pathogenic Progression in the Mortality and Atherosclerotic Events: A National Cohort Study. Otol Neurotol. 2018; 39(10):1241-1249. DOI: 10.1097/MAO.0000000000001967. View

17.

Lee M, Lee J, Lee H, Choi J, Jang J, Choi H . Continuous topical drug delivery using osmotic pump in animal cochlear implant model: Continuous steroid delivery is effective for hearing preservation. Acta Otolaryngol. 2015; 135(8):791-8. DOI: 10.3109/00016489.2015.1030771. View

18.

Guzik T, Korbut R, Adamek-Guzik T . Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol. 2004; 54(4):469-87. View

19.

Shikata C, Nemoto M, Ebisawa T, Nishiyama A, Takeda N . Effect of sarpogrelate on cardiovascular disorders. Exp Clin Cardiol. 2011; 16(3):75-6. PMC: 3209543. View

20.

Farhadi M, Jalessi M, Salehian P, Ghavi F, Emamjomeh H, Mirzadeh H . Dexamethasone eluting cochlear implant: Histological study in animal model. Cochlear Implants Int. 2012; 14(1):45-50. DOI: 10.1179/1754762811Y.0000000024. View